The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya

ConditionAutism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age24-72
SponsorIndiana University

About this trial

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).

Eligibility criteria

Qualifiers

Children enrolled in the Tabiri study (R01HD104552)

CHEU or CHUU

Children ages 24-72 months

Caregivers of children must speak Kiswahili (local language) or English.

Disqualifiers

There will be no specific exclusion criteria. We anticipate that a small number of CHEU and CHUU will develop HIV prior to enrollment in the current study; these children will be included and will follow all general study procedures.

Trial design

Treatments tested in this trial

  • Eyelink Portable Duo

Treatment groups

850 Participants
are divided into 1 treatment group

Sponsors and collaborators

Indiana University

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator